Nestle Said to Plan Pfizer Asset Sales to Sooth Regulator

Nestle SA may sell as much as $1.8 billion of the infant-nutrition assets it is buying from Pfizer Inc. as antitrust concerns in countries such as Mexico force divestitures, said people with knowledge of the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.